Occular
Cortical, Electronic, Preclinical

Occular is a visual prosthesisa device intended to create visual percepts by stimulating the visual system designed to restore both peripheral and central vision by incorporating a high count of electrodes directly into the visual cortex. It uses advanced stimulation patterns to achieve higher resolution. The device is based on flexible micro-electrode technology, minimizing scar tissue formation and enabling high resolution. The ultra-flexible electrode arrays, made from soft, biocompatiblethe ability of a material or device to function without causing an unacceptable biological response materials, move with the brain's tissue to minimize irritation and scar tissue formation.
ReVision, the company behind Occular, has developed a patented scalable insertion mechanism, allowing neurosurgeons to implant over 1000 electrodes efficiently. This technique has demonstrated long-term performance with minimal tissue damage in animal models. The device's advanced stimulation algorithm research aims to improve resolution, ensuring users can navigate daily life with image quality equivalent to a greyscale image of over 1000 pixels.
In 2024, ReVision Implant started safety and functionality testing on trained rhesus monkeys and sheep with external electronics. By the end of 2024, the IC should be available for pre-clinical testing.
Article information
How verification worksVersion 1: July 03, 2025 at 4:02 PM.
Information on this page was independently verified & approved by:
- Frederik CeyssensCo-Founder & CEO, ReVision Implant
(verification imported from the legacy site)
The following people contributed to this page:
- Michael BeyelerAssociate Professor, UC Santa Barbara

